OTCMKTS:PVTTF

Pivotal Therapeutics Stock Forecast, Price & News

$0.05

0.00 (0.00 %)

(As of 03/3/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.04

Now: $0.05▼

$0.16

50-Day Range

$0.01

MA: $0.03▼

$0.05

52-Week Range

$0.00

Now: $0.05▼

$0.16

Volume11,000 shs

Average Volume20,227 shs

Market Capitalization$4.49 million

P/E RatioN/A

Dividend YieldN/A

Beta1.01

Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:PVTTF

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.pivotaltherapeutics.us

Phone905-856-9797

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares91,920,000

Market Cap$4.49 million

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.58 out of 5 stars

Medical Sector

1378th out of 1,968 stocks

Pharmaceutical Preparations Industry

609th out of 772 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Pivotal Therapeutics.

2.9 Community Rank

Outperform Votes
Pivotal Therapeutics has received 63 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Pivotal Therapeutics has received 46 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Pivotal Therapeutics has received 57.80% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Pivotal Therapeutics and other stocks. Vote “Outperform” if you believe PVTTF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PVTTF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Pivotal Therapeutics does not currently pay a dividend.
Dividend Growth
Pivotal Therapeutics does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pivotal Therapeutics insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$0.05

0.00 (0.00 %)

(As of 03/3/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive PVTTF News and Ratings via Email

Sign-up to receive the latest news and ratings for PVTTF and its competitors with MarketBeat's FREE daily newsletter.

Pivotal Therapeutics (OTCMKTS:PVTTF) Frequently Asked Questions

What stocks does MarketBeat like better than Pivotal Therapeutics?

Wall Street analysts have given Pivotal Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pivotal Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Pivotal Therapeutics' stock price been impacted by Coronavirus (COVID-19)?

Pivotal Therapeutics' stock was trading at $0.0035 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PVTTF shares have increased by 1,295.7% and is now trading at $0.0489.
View which stocks have been most impacted by COVID-19.

Who are Pivotal Therapeutics' key executives?

Pivotal Therapeutics' management team includes the following people:

Ms. Rachelle MacSweeney, Co-Founder, CEO, Pres & Director
Mr. George Jackowski, Co-Founder, Chief Scientific Officer & Director (Age 70)

Who are some of Pivotal Therapeutics' key competitors?

Some companies that are related to Pivotal Therapeutics include Teligent (TLGT), XTL Biopharmaceuticals (XTLB), Wize Pharma (WIZP), Sonoma Pharmaceuticals (SNOA), GlobeImmune (GBIM), Bioxytran (BIXT), MedAvail (MDVL), Xenetic Biosciences (XBIO), Nuvo Pharmaceuticals (NRIFF), Histogen (HSTO), iCo Therapeutics (ICOTF), Intec Pharma (NTEC), Benitec Biopharma (BNTC), Novelion Therapeutics (NVLNF) and Synthetic Biologics (SYN).
View all of PVTTF's competitors.

What is Pivotal Therapeutics' stock symbol?

Pivotal Therapeutics trades on the OTCMKTS under the ticker symbol "PVTTF."

How do I buy shares of Pivotal Therapeutics?

Shares of PVTTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pivotal Therapeutics' stock price today?

One share of PVTTF stock can currently be purchased for approximately $0.05.

How much money does Pivotal Therapeutics make?

Pivotal Therapeutics has a market capitalization of $4.49 million.

What is Pivotal Therapeutics' official website?

The official website for Pivotal Therapeutics is www.pivotaltherapeutics.us.

How can I contact Pivotal Therapeutics?

The company can be reached via phone at 905-856-9797.

This page was last updated on 3/4/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here